Overview

Clinical Microbiology Market Introduction:

Global Clinical Microbiology Market is estimated to value over USD 5.9 billion by 2027 end and register a CAGR of over 6.2% during the forecast period 2020 to 2027. 

Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth.

Additionally, as per a few observations that were published in the Journal of the American Medical Association (AMA), persistent respiratory diseases were the reason for over 1 in every 20 deaths in 2015. In 2013, around USD 130 billion of healthcare expenditures were related to these diseases. Blood tests, bronchoscopy and biopsy are commonly utilized tools for diagnosing respiratory diseases. Thus, increasing incidences of persistent respiratory diseases is an integral factor stimulating the global clinical microbiology market growth. 

The market is segmented on the basis of end users as academic and research institutes, custom lab service providers and hospitals and diagnostic centres. The custom lab service providers are predicted to showcase the highest proliferation over the forecast period due to the drug testing processes that are continuously outsources to laboratory services by pharmaceutical companies, benefits provided by the procedures of advanced molecular technology-based instruments like NGS and PCR in discovering drugs, rising number of clinical trials based on microbiology and the increasing number of service providers of custom labs across key market regions.

Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen.

Clinical Microbiology Market Segmentation:

By Application

• Pharmaceutical Applications
• Food Testing Applications
• Clinical Applications
• Energy Applications
• Chemical & Material Manufacturing Applications
• Environmental Applications

By Product

• Instruments
• Laboratory Instruments
• Incubators
• Gram Stainers
• Bacterial Colony Counters
• Autoclave Sterilizers
• Microbial Air Samplers
• Anaerobic Culture Systems
• Petri Dish Fillers
• Blood Culture Systems
• Microbial Culture Systems
• Other Laboratory Instruments
• Microbiology Analyzers
• Molecular Diagnostic Instruments
• Microscopes
• Mass Spectrometers
• Reagents
• Pathogen-Specific Kits
• General Reagents

 By Indication

• Respiratory Diseases
• Bloodstream Infections
• Gastrointestinal Diseases
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Periodontal Diseases
• Other Indications

By End User

• Hospitals & Diagnostic Centres
• Custom Lab Service Providers
• Academic & Research Institutes

By Region 

• North America
• Europe
• Asia Pacific
• Rest of the World 

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis 
• Key trends 
• Key data-points affecting market growth 

Objectives of the Study:

• To provide with an exhaustive analysis on the global clinical microbiology market by application, by product, by indication, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Geographic Scope

           1.3.3 Years Considered for the Study

    1.4 Currency and Pricing 

    1.5 Stakeholders 

2 Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Data

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Data

                    2.1.2.1 Key Data From Primary Sources

                    2.1.2.2 Breakdown of Primaries

    2.2 Opportunity Indicators 

           2.2.1 Introduction

           2.2.2 Demand-Side Analysis

                    2.2.2.1 Burden of Infectious Diseases

                    2.2.2.2 Healthcare Expenditure Patterns

                    2.2.2.3 Rapid Growth in the Geriatric Population

           2.2.3 Supply-Side Analysis

                    2.2.3.1 Number of New Clinical Microbiology Products Launched

    2.3 Market Size Estimation 

           2.3.1 Bottom-Up Approach

           2.3.2 Top-Down Approach

    2.4 Market Breakdown and Data Triangulation 

    2.5 Research Limitations and Assumptions 

           2.5.1 Limitations

           2.5.2 Assumptions

3 Executive Summary 

4 Exclusive Insights 

    4.1 Microbiology Testing Market (2020–2027) 

    4.2 Microbiology Testing Market, By Application, 2020–2027 (USD Billion) 

    4.3 Clinical Microbiology Market (2020–2027) 

    4.4 Clinical Microbiology Products Market, By Region (2020) 

    4.5 Market, By Indication, 2020 vs 2027 (USD Million) 

    4.6 Geographic Analysis: Market, By End User, 2020 vs 2027 (USD Million) 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Technological Advancements in Disease Diagnostics

                    5.2.1.2 Rising Incidence of Infectious Diseases and Growing Outbreaks of Epidemics

                    5.2.1.3 Increased Funding and Public-Private Investments

           5.2.2 Restraints

                    5.2.2.1 Limited Reimbursement Policies for Microbiology Testing Procedures

                    5.2.2.2 Budget Cuts, Customs Duties, and Additional Taxes Levied

           5.2.3 Opportunities

                    5.2.3.1 Emerging Countries

           5.2.4 Challenges

                    5.2.4.1 Operational Barriers Related to the Use of Diagnostic Tests

                    5.2.4.2 Bundled Sales of Microbiology Testing Products—A Key Challenge for Small and Emerging Reagent Manufacturers

6 Microbiology Testing Market, By Application 

    6.1 Introduction 

    6.2 Pharmaceutical Applications 

    6.3 Food Testing Applications 

    6.4 Clinical Applications 

    6.5 Energy Applications 

    6.6 Chemical & Material Manufacturing Applications 

    6.7 Environmental Applications 

7 Market, By Product 

    7.1 Introduction 

    7.2 Instruments 

           7.2.1 Laboratory Instruments

                    7.2.1.1 Incubators

                    7.2.1.2 Gram Stainers

                    7.2.1.3 Bacterial Colony Counters

                    7.2.1.4 Autoclave Sterilizers

                    7.2.1.5 Microbial Air Samplers

                    7.2.1.6 Anaerobic Culture Systems

                    7.2.1.7 Petri Dish Fillers

                    7.2.1.8 Blood Culture Systems

                    7.2.1.9 Microbial Culture Systems

                    7.2.1.10 Other Laboratory Instruments

           7.2.2 Microbiology Analyzers

                    7.2.2.1 Molecular Diagnostic Instruments

                    7.2.2.2 Microscopes

                    7.2.2.3 Mass Spectrometers

    7.3 Reagents 

           7.3.1 Pathogen-Specific Kits

           7.3.2 General Reagents

8 Market, By Indication 

    8.1 Introduction 

    8.2 Respiratory Diseases 

    8.3 Bloodstream Infections 

    8.4 Gastrointestinal Diseases 

    8.5 Sexually Transmitted Diseases 

    8.6 Urinary Tract Infections 

    8.7 Periodontal Diseases 

    8.8 Other Indications 

9 Market, By End User 

    9.1 Introduction 

    9.2 Hospitals & Diagnostic Centers 

    9.3 Custom Lab Service Providers 

    9.4 Academic & Research Institutes 

10 Microbiology Testing Market, By Region 

     10.1 Introduction 

     10.2 North America 

             10.2.1 US

             10.2.2 Canada

     10.3 Europe 

             10.3.1 Germany

             10.3.2 UK

             10.3.3 France

             10.3.4 Rest of Europe

     10.4 Asia Pacific 

             10.4.1 Japan

             10.4.2 China

             10.4.3 India

             10.4.4 Rest of APAC

     10.5 Rest of the World (RoW) 

             10.5.1 Latin America

             10.5.2 Middle East & Africa

11 Competitive Landscape 

     11.1 Overview 

     11.2 Market Share Analysis 

     11.3 Competitive Scenario 

             11.3.1 Key Product Launches & Approvals (2017–2020)

             11.3.2 Key Agreements, Partnerships, & Collaborations (2017–2020)

             11.3.3 Key Acquisitions & Divestments (2017–2020)

             11.3.4 Key Expansions (2017–2020)

12 Company Profiles 

     12.1 Biomérieux 

     12.2 Danaher Corporation 

     12.3 Becton, Dickinson and Company 

     12.4 Abbott 

     12.5 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.) 

     12.6 Bruker 

     12.7 Hologic 

     12.8 Bio-Rad 

     12.9 Qiagen 

     12.10 Thermo Fisher Scientific 

     12.11 Agilent 

     12.12 Merck KGaA 

     12.13 Shimadzu 

     12.14 3M 

     12.15 Neogen

Chapter 13 Research Finding and Conclusion 

Chapter 14  Research Methodology 

Chapter 15  Research Data Source   

Tables

Figures